Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes

Pharmaceutics, 2023 · DOI: 10.3390/pharmaceutics15092235 · Published: August 29, 2023

Simple Explanation

Salvianolic acid B, derived from Danshen, exhibits antitumor and anti-inflammatory properties across various organs and tissues, offering protective benefits in conditions like depression and spinal cord injury. Its mechanisms primarily involve anti-inflammatory, antioxidant, and metabolism-regulating functions, impacting different signaling pathways and cells to maximize therapeutic effects. This review summarizes the safety profile, combination therapy potential, and innovative dosage forms and delivery methods, providing valuable insights for future research and development of salvianolic acid B.

Study Duration

Not specified

Participants

Number and description or 'Not specified'

Evidence Level

Level and study type or 'Not specified'

Key Findings

1
Salvianolic acid B demonstrates antitumor effects by inducing apoptosis, autophagy, and oxidative stress, enhancing T cell activity, and inhibiting EMT and tumor cell proliferation across various cancers.
2
It protects against lung diseases by inhibiting inflammatory cytokines and fibrosis markers, and against cerebral nerve damage by exerting antioxidant and anti-inflammatory effects and promoting autophagy.
3
Salvianolic acid B shows cardioprotective effects through antioxidant, antiapoptotic, anti-inflammatory, and anti-fibrotic mechanisms, preventing iron-dependent cell death and promoting angiogenesis.

Research Summary

Salvianolic acid B, extracted from Danshen, exhibits diverse pharmacological effects, including antitumor, anti-inflammatory, antioxidant, and neuroprotective activities, making it a valuable compound in traditional Chinese medicine. The review consolidates information on its safety, potential for combination therapy, and development of new dosage forms and delivery routes to enhance its therapeutic efficacy and clinical applications. Despite its potential, salvianolic acid B faces challenges such as poor stability and bioavailability, necessitating further research into improved formulations and targeted delivery systems to fully realize its clinical benefits.

Practical Implications

Drug Development

Salvianolic acid B shows promise as a therapeutic agent for various diseases, including cancer, cardiovascular disorders, and neurological conditions. Further research could lead to the development of novel drugs based on this compound.

Combination Therapies

Combining salvianolic acid B with other therapeutic agents, such as ginsenoside Rg1 or tanshinone IIA, can enhance its efficacy and address multiple disease pathways simultaneously.

Novel Dosage Forms

Developing new dosage forms and drug delivery routes, such as nanoparticles, liposomes, and dry powder inhalers, can improve the stability, bioavailability, and targeted delivery of salvianolic acid B, enhancing its therapeutic potential.

Study Limitations

1
Poor stability and bioavailability of salvianolic acid B
2
Limited clinical research on combination therapies and novel dosage forms
3
Lack of detailed understanding of specific mechanisms of action for all therapeutic effects

Your Feedback

Was this summary helpful?

Back to Alternative Medicine